Gabapentin
NDC 50228-178, Gabapentin, tablet, from ScieGen Pharmaceuticals, Inc..
- Product NDC
- 50228-178
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205101
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-178 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN800 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-178-01 | 50228017801 | 100 TABLET in 1 BOTTLE (50228-178-01) |
| 50228-178-05 | 50228017805 | 500 TABLET in 1 BOTTLE (50228-178-05) |
| 50228-178-30 | 50228017830 | 30 TABLET in 1 BOTTLE (50228-178-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5ab9c18b-9568-4dcb-90b0-252aef8f8dc2NADAC price for package 50228017801
GET /v1/drugs/nadac/50228017801NADAC price for package 50228017805
GET /v1/drugs/nadac/50228017805
Use it
Look up 50228-178 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-178 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-178. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.